Sign In

John Brownstein

Chief Innovation Officer | Professor | Epidemiologist

John Brownstein is an accomplished infectious disease epidemiologist and a prominent figure in the field of public health.

He serves as a Professor at Harvard Medical School, where he imparts his extensive knowledge and expertise to the next generation of healthcare professionals.

In addition to his academic role, John Brownstein holds the position of Chief Innovation Officer at Boston Children's Hospital, a role that allows him to drive innovation and advancements in healthcare.

With a strong educational background that includes studying at Yale School of Public Health and McGill University, Brownstein is well-equipped to tackle complex public health challenges.

Throughout his career, Brownstein has held key positions in various prestigious organizations, including Senior Vice President at Boston Children's Hospital, Medical Contributor at ABC News, and Healthcare advisor at Uber.

He is also known for his entrepreneurial spirit, having co-founded successful ventures such as Circulation, Inc. (later acquired by Modivcare) and Epidemico (later acquired by Booz Allen Hamilton).

His diverse experience, from academia to industry, highlights his versatility and deep understanding of the healthcare landscape.

John Brownstein's reputation as a thought leader in infectious diseases and epidemiology is further solidified by his contributions to both medical research and public health policy.

As a respected medical contributor at ABC News, he plays a vital role in translating complex health information for the general public, making him a trusted source of healthcare insights.

His multifaceted career trajectory reflects his commitment to making a meaningful impact on healthcare delivery, innovation, and education.

Highlights

Jul 23 · twitter

Exciting new work from @thekaransinghal and the heatlh team at @OpenAI

Jul 10 · linkedin

AI promises to revolutionize healthcare by enhancing diagnosis, treatment, and patient safety. Yet, a critical gap exists between AI research and its real-world impact. We urgently need comprehensive clinical effectiveness evaluations to bridge this divide.

My colleagues at UC San Diego Health, UC Davis Health, and I published this article in the NEJM AI to establish boundaries for using AI in the healthcare setting, bringing together research and real-world evidence for comprehensive clinical effectiveness. AI is bound to revolutionize our industry that was traditionally adverse to change, yet it is essential to collaborate on the shared goal of safer, more effective, and equitable care for all patients. Christopher Longhurst Karandeep Singh Aneesh Chopra Ashish Atreja, MD, MPH

Our call to action:

(1) Move Beyond Model Validation: It's essential to validate AI models not just through simulations but in real-world clinical settings, akin to clinical trials for new drugs.

(2) Focus on Local Context: The importance of local health care contexts in AI model validation cannot be overstated. Different settings require tailored approaches for optimal outcomes.

(3) Implement Science Principles: Adopting implementation science principles will ensure that AI tools are effectively integrated into health care workflows, resulting in tangible improvements in patient outcomes.

A robust network of healthcare delivery organizations is crucial to focus on the clinical effectiveness of AI models in real-world settings. This collaborative approach will help us achieve safer, more effective, and equitable care for all patients.

#HealthcareInnovation #AIinHealthcare #ClinicalEffectiveness #PatientSafety #ImplementationScience #AIValidation #EquitableCare #HealthTech

John Brownstein
Add to my network

Location

Boston, Massachusetts, United States